{"symbol": "VSTM", "companyName": "Verastem Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.verastem.com", "description": "Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.", "CEO": "Robert Forrester", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}